Summary
HCA Healthcare, Inc. (HCA) has filed an 8-K report on August 12, 2024, detailing the completion of a significant public offering of senior notes totaling $3,000,000,000 in aggregate principal amount. This offering consists of three tranches: $750,000,000 of 5.450% Senior Notes due 2031 (New 2031 Notes), $1,250,000,000 of 5.450% Senior Notes due 2034 (2034 Notes), and $1,000,000,000 of 5.950% Senior Notes due 2054 (2054 Notes). These notes are senior unsecured obligations of HCA Inc., guaranteed on a senior unsecured basis by the Parent Guarantor, HCA Healthcare, Inc. The issuance of these notes is a material event for investors as it impacts the company's capital structure and long-term financing. The proceeds from this offering will be used to refinance existing debt and for general corporate purposes, though specific use of proceeds beyond that is not detailed in this filing. The tiered interest rates and maturity dates reflect market conditions and the company's debt management strategy. Investors should note the covenants and change of control provisions detailed in the Indentures, which offer certain protections.
Key Highlights
- 1HCA Healthcare completed a $3 billion senior notes offering on August 12, 2024.
- 2The offering includes $750 million in 5.450% notes due 2031, $1.25 billion in 5.450% notes due 2034, and $1 billion in 5.950% notes due 2054.
- 3The notes are guaranteed on a senior unsecured basis by HCA Healthcare, Inc.
- 4The New 2031 Notes ($750M) are an additional issuance fungible with existing 2031 notes, bringing the total 2031 notes to $1.75 billion.
- 5The Indentures contain covenants restricting liens, sale and lease-back transactions, and major asset dispositions.
- 6A change of control provision, coupled with a ratings downgrade, allows noteholders to require repurchase at 101% of principal plus accrued interest.